Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 33.90
-0.25 (-0.73%)
Sep 8, 2026, 1:19 PM CST
Sofiva Genomics Market Cap
Sofiva Genomics has a market cap or net worth of 732.02 million as of September 8, 2026. Its market cap has increased by 8.48% in one year.
Market Cap
732.02M
Enterprise Value
638.54M
Revenue
379.21M
Ranking
n/a
PE Ratio
51.67
Stock Price
33.90
ChartMarket Cap Chart
Since January 5, 2017, Sofiva Genomics's market cap has decreased from 1.70B to 732.02M, a decrease of -56.91%. That is a compound annual growth rate of -8.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 732.02M | 12.44% |
| Dec 31, 2025 | 651.04M | -24.53% |
| Dec 31, 2024 | 862.66M | -1.51% |
| Dec 29, 2023 | 875.86M | 11.72% |
| Dec 30, 2022 | 784.00M | -24.75% |
| Dec 30, 2021 | 1.04B | -4.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.95B |
| DIVA Laboratories | 1.91B |
| Puriblood Medical | 1.07B |
| Genetics Generation Advancement | 1.05B |
| Kim Forest Enterprise | 745.74M |
| TFBS Bioscience | 663.84M |
| Welgene Biotech | 379.86M |
| Pharmigene | 368.90M |